Key Findings

1. Weiss MS, Luo C, Zhang Y, Chen Y, Kissin DM, Satten GA, Barnhart KT. Fresh vs. frozen embryo transfer: new approach to minimize the limitations of using national surveillance data for clinical research. Fertil Steril. 2023 Feb;119(2):186-194. doi: 10.1016/j.fertnstert.2022.10.021. Epub 2022 Dec 23.
2. Lee JC, DeSantis CE, Boulet SL, Kawwass JF. Embryo donation: national trends and outcomes, 2004-2019. Am J Obstet Gynecol 2022; Online ahead of print.
3. Lee JC, DeSantis CE, Yartel AK, Kissin DM, Kawwass JF. Association of state insurance coverage mandates with assisted reproductive technology care discontinuation. Am J Obstet Gynecol 2022; Online ahead of print.
4. Roshong AJ, DeSantis CE, Yartel AK, Heitmann RJ, Kissin DM, Pier BD. Factors Associated with Large for Gestational Age Infants Born after Frozen Embryo Transfer Cycles. F&S Reports (2022) Sep 9;3(4):332-341. doi: https://doi.org/10.1016/j.xfre.2022.09.002.
5. Anyalechi GE, Hong J, Kirkcaldy RD, Wiesenfeld HC, Horner P, Wills GS, McClure MO, Hammond KR, Haggerty CL, Kissin DM, Hook EW 3rd, Steinkampf MP, Bernstein K, Geisler WM. Chlamydial Pgp3 Seropositivity and Population-Attributable Fraction Among Women With Tubal Factor Infertility. Sex Transm Dis. 2022 Aug 1;49(8):527-533. doi: 10.1097/OLQ.0000000000001434. Epub 2021 Mar 31.
6. Jewett A, Warner L, Kawwass J, Mehta A, Eisenberg M, Nangia A, Dupree J, Honig S, Hotaling J, Kissin D. Assisted reproductive technology (ART) cycles involving male factor infertility in the United States, 2017-2018: Data from the National ART Surveillance System (NASS). F&S Reports (2022), doi: https://doi.org/10.1016/j.xfre.2022.03.004.
7. Sunderam S, Kissin DM, Zhang Y, Jewett A, Boulet SL, Warner L, Kroelinger CD, Barfield WD. Assisted Reproductive Technology Surveillance – United States, 2018. MMWR Surveill Summ. 2022;71(4):1-24.

1. Anyalechi GE, Wiesenfeld HC, Kirkcaldy RD, Kissin DM, Haggerty CL, Hammond KR, Hook EW 3rd, Bernstein KT, Steinkampf MP, Geisler WM. Tubal Factor Infertility, In Vitro Fertilization, and Racial Disparities: A Retrospective Cohort in Two US Clinics. Sex Transm Dis. 2021 Oct 1;48(10):748-753. doi: 10.1097/OLQ.0000000000001435.
2. Chang J, Zhang Y, Boulet SL, Crawford SB, Copeland GE, Bernson D, Kirby RS, Kissin DM, Barfield WD, for States Monitoring Assisted Reproductive Technology (SMART) Collaborative. Assisted Reproductive Technology and Perinatal Mortality: Selected States (2006-2011). Am J Perinatol. 2021. Jul 19. doi: 10.1055/s-0041-1732451.

1. Sunderam S, Kissin DM, Zhang Y, Jewett A, Boulet SL, Warner L, Kroelinger CD, Barfield WD. Assisted Reproductive Technology Surveillance – United States, 2017. MMWR Surveill Summ. 2020;69(9):1-24.
2. Schirmer DA 3rd, Kulkarni AD, Zhang Y, Kawwass JF, Boulet SL, Kissin DM. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy. Fertil Steril. 2020;114(3):567-578.
3. Sites CK, Wilson D, Bernson D, Boulet S, Zhang Y. Number of embryos transferred and diagnosis of preeclampsia. Reprod Biol Endocrinol. 2020;18(1):68.
4. Sunderam S, Boulet SL, Kawwass JF, and Kissin DM. Comparing fertilization rates from intracytoplasmic sperm injection to conventional in vitro fertilization among women of advanced age with non-male factor infertility: a meta-analysis. Fertil Steril. 2020;113(2):354-363.

1. Schwartz KM, Boulet SL, Kawwass JF, and Kissin DM. Perinatal outcomes among young donor oocyte recipients. Human Reprod. 2019;34(12):2553-2540.
2. Boulet SL, Zhou Y, Shriber J, Kissin DM, Strosnider H, Shin M. Ambient air pollution and in vitro fertilization treatment outcomes. Hum Reprod. 2019;34(10):2036-2043.
3. Anyalechi, GE, Hong, J, Kreisel, K, Torrone, E, Boulet, S, Gorwitz, R, Kirkcaldy, R, and Bernstein, K. Self-Reported Infertility and Associated Pelvic Inflammatory Disease Among Women of Reproductive Age—National Health and Nutrition Examination Survey, United States, 2013–2016. Sexually Transmitted Diseases. 2019;46(7):446–451.
4. Narvaez JL, Chang J, Boulet SL, Davies MJ, and Kissin DM. Trends and correlates of the sex distribution among U.S. assisted reproductive technology births. Fertil Steril. 2019;112(2):305-314.
5. Rockhill K, Tong VT, Boulet SL, Zhang Y, Jamieson DJ, and Kissin DM. Smoking and Clinical Outcomes of Assisted Reproductive Technologies. J Women’s Health. 2019;28(3):314-322.
6. Boulet SL, Kawwass JF, Session D, Jamieson DJ, Kissin DM, Grosse SD. US State-Level Infertility Insurance Mandates and Health Plan Expenditures on Infertility Treatments. Matern Child Health J. 2019;23(5):623-632.
7. Sunderam S, Kissin DM, Zhang Y, Folger SG, Boulet SL, Warner L, Barfield WD. Assisted Reproductive Technology Surveillance – United States, 2016. MMWR Surveill Summ. 2019;68(4):1-28.

1. Boulet SL, Kissin DM. Temporal Differences in Utilization of Intracytoplasmic Sperm Injection Among U.S. Regions. Obstet Gynecol. 2018;132(5):1302-1303.
2. Sunderam S, Boulet SL, Jamieson DJ, Kissin DM. Effects of patient education on desire for twins and use of elective single embryo transfer procedure during ART treatment: A systematic review. Reprod Biomed Soc Online. 2018;6;102-119.
3. Klenov VE, Boulet SL, Mejia RB, Kissin DM, Munch E, Mancuso A, Van Voorhis BJ. Live birth and multiple birth rates in US in vitro fertilization treatment using donor oocytes: a comparison of single-embryo transfer and double-embryo transfer. J Assist Reprod Genet. 2018;35(9):1657-1664.
4. Palmsten K, Homer MV, Zhang Y, Crawford S, Kirby RS, Copeland G, Chambers CD, Kissin,DM, Su HI, States Monitoring Assisted Reproductive Technology (SMART) Collaborative. In vitro fertilization, interpregnancy interval, and risk of adverse perinatal outcomes. Fertil Steril. 2018;109(5):840-848.
5. Litzky JF, Boulet SL, Esfandiari N, Zhang Y, Kissin DM, Theiler RN, Marsit CJ. Birthweight in infants conceived through in vitro fertilization following blastocyst or cleavage-stage embryo transfer: a national registry study. J Assist Reprod Genet. 2018;35(6):1027-1037.
6. Kawwass JF, Boulet SL, Hipp HS, Session DR, Kissin DM, Jamieson DJ. Severity of Diminished Ovarian Reserve and Chance of Success with Assisted Reproductive Technology. J Reprod Med. July – Aug. 2018; 63 (no. 7-8).
7. Sunderam S, Kissin DM, Crawford SB, et al. Assisted Reproductive Technology Surveillance — United States, 2015. MMWR Surveill Summ 2018;67(No. SS-3):1–28.
8. Dieke AC, Mehta A, Kissin DM, Nangia AK, Warner L, Boulet SL. Intracytoplasmic Sperm Injection (ICSI) Use in States with and without Insurance Coverage Mandates for Infertility Treatment, United States, 2000-2015. Fertil Steril. 2018;109(4):691-7.
9. Gerkowicz SA, Crawford SB, Hipp HS, Boulet SL, Kissin DM, Kawwass JF. Assisted Reproductive Technology with Donor Sperm: National Trends and Perinatal Outcomes. Am J Obstet Gynecol. 2018;218(4):421.e1-421.e10.
10. Litzky JF, Boulet SL, Esfandiari N, Zhang Y, Kissin DM, Theiler RN, Marsit CJ. Effect of Frozen/Thawed Embryo Transfer on Birthweight, Macrosomia, and Low Birthweight Rates in us Singleton Infants. Am J Obstet Gynecol. 2018;218(4):433.e1-433.e10.
11. Kawwass JF, Chang J, Boulet SL, Nangia A, Mehta A, Kissin DM. Surgically acquired sperm use for assisted reproductive technology: trends and perinatal outcomes, USA, 2004-2015. J Assist Reprod Genet. 2018;35(7):1229-1237.
12. Boulet SL, Kawwass JF, Crawford S, Davies MJ, Kissin DM. Preterm Birth and Small-for-Gestational Age in Singleton In Vitro Fertilization Births Using Donor Oocytes. Am J Epidemiol. 2018;187(8):1642-50.

1. Perkins KM, Boulet SL, Levine AD, Jamieson DJ, Kissin DM. Differences in the utilization of gestational surrogacy between states in the USA. Reprod Biomed Soc Online. 2017;28;1-4.
2. Sites CK, Wilson D, Barsky M, Bernson D, Bernstein IM, Boulet S, Zhang Y. Embryo cryopreservation and preeclampsia risk. Fertil Steril. 2017;108:784-790.
3. Levine AD, Boulet SL, Berry RM, Jamieson DJ, Alberta-Sherer HB, Kissin DM. Assessing the use of assisted reproductive technology in the United States by non-United States residents.Fertil Steril. 2017;180:825-821.
4. Brooks JT, Kawwass JF, Smith DK, Kissin DM, Lampe M, Haddad LB, Boulet SL, Jamieson DJ. Effects of Antiretroviral Therapy to Prevent HIV Transmission to Women in Couples Attempting Conception When the Man Has HIV Infection – United States, 2017.MMWR Morb Mortal Wkly Rep. 2017;66(32):859-860.
5. Kulkarni AD, Adashi EY, Jamieson DJ, Crawford SB, Sunderam S, Kissin DM. Affordability of Fertility Treatments and Multiple Births in the United States. Paediatr Perinat Epidemiol. 2017;31:438-488.
6. Kirby RS, Boulet SL. Birth Defect Outcomes in Pregnancies Conceived through In Vitro Fertilisation. Paediatr Perinat Epidemiol. 2017;31:479-480.
7. Dunietz GL, Holzman C, Zhang Y, Li C, Todem D, Boulet SL, McKane P, Kissin DM, Copeland G, Bernson D, Diamond MP. Assisted reproduction and risk of preterm birth in singletons by infertility diagnoses and treatment modalities: a population-based study. J Assist Reprod Genet. 2017;34:1529-1535.
8. Boulet SL, Smith RA, Crawford S, Kissin DM, Warner L. Health-Related Quality of Life for Women Ever Experiencing Infertility or Difficulty Staying Pregnant. Matern Child Health J. 2017;21:1918-1926.
9. Dieke AC, Zhang Y, Kissin DM, Barfield WD, Boulet SL. Disparities in Assisted Reproductive Technology Utilization by Race and Ethnicity, United States, 2014: A Commentary. J Womens Health. 2017;26:605-608.
10. Kawwass JF, Smith DK, Kissin DM, Haddad LB, Boulet SL, Sunderam S, Jamieson DJ. Strategies for Preventing HIV Infection Among HIV-Uninfected Women Attempting Conception with HIV-Infected Men — United States. MMWR Morb Mortal Wkly Rep 2017;66:554–557.
11. Zhang Y, Crawford S, Boulet S, Monsour M, Cohen B. Using multiple imputation to address missing values of hierarchical data. Journal of Modern Applied Statistical Methods. 2017;16:744-52.
12. Crawford S, Joshi N, Boulet SL, Bailey MA, Hood ME, Manning SE, McKane P, Kirby RS, Kissin DM, Jamieson DJ; States Monitoring Assisted Reproductive Technology (SMART) Collaborative. Maternal Racial and Ethnic Disparities in Neonatal Birth Outcomes With and Without Assisted Reproduction. Obstet Gynecol. 2017;129: 1022-1030.
13. Hipp H, Crawford S, Kawwass JF, Boulet SL, Grainger DA, Kissin DM, Jamieson D. National trends and outcomes of autologous in vitro fertilization cycles among women ages 40 years and older. J Assist Reprod Genet. 2017;34: 885-894.
14. Levine AD, Boulet SL, Kissin DM. Contribution of Assisted Reproductive Technology to Overall Births by Maternal Age in the United States, 2012-2014. JAMA. 2017;317(12):1272-1273.
15. Martin AS, Chang J, Zhang Y, Kawwass JF, Boulet SL, McKane P, Bernson D, Kissin DM, Jamieson DJ; States Monitoring Assisted Reproductive Technology (SMART) Collaborative. Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology. Fertil Steril. 2017;107(4):954-960.
16. Sunderam S, Kissin DM, Crawford SB, Folger SG, Jamieson DJ, Warner L, Barfield WD. Assisted Reproductive Technology Surveillance – United States, 2014. MMWR Surveill Summ. 2017;66(6):1-24.
17. Gorwitz RJ, Wiesenfeld HC, Chen PL, Hammond KR, Sereday KA, Haggerty CL, Johnson RE, Papp JR, Kissin DM, Henning TC, Hook EW 3rd, Steinkampf MP, Markowitz LE, Geisler WM. Population-attributable fraction of tubal factor infertility associated with chlamydia. Am J Obstet Gynecol. 2017;217:336.e1-336.e16.
18. Levi Dunietz G, Holzman C, Zhang Y, Talge NM, Li C, Todem D, Boulet SL, McKane P, Kissin DM, Copeland G, Bernson D, Diamond MP. Assisted Reproductive Technology and Newborn Size in Singletons Resulting from Fresh and Cryopreserved Embryos Transfer. PLoS One. 2017;12(1):e0169869.
19. Crawford S, Boulet SL, Kawwass JF, Jamieson DJ, Kissin DM. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013. Fertil Steril. 2017;107(1):110-118.
20. Rao PK, Boulet SL, Mehta A, Hotaling J, Eisenberg ML, Honig SC, Warner L, Kissin DM, Nangia AK, Ross LS. Trends in Testosterone Replacement Therapy Use Among Reproductive-Age US Men, 2003-2013. J Urol. 2017;197(4):1121-1126.

 Top of Page

1. Sunderam S, Kissin DM, Crawford SB, et al. Assisted Reproductive Technology Surveillance — United States, 2014. MMWR Surveill Summ 2017;66(No. SS-6):1–24.
2. Crawford S, Boulet SL, Kawwass JF, Jamieson DJ, Kissin DM. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013. Fertil Steril. 2017;107(1):110-118.
3. Kawwass JF, Kulkarni AD, Hipp HS, Crawford S, Kissin DM, Jamieson DJ. Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States. Fertil Steril. 2016;106(7):1742-1750.
4. Tong VT, Kissin DM, Bernson D, Copeland G, Boulet SL, Zhang Y, Jamieson DJ, England LJ. Maternal Smoking Among Women With and Without Use of Assisted Reproductive Technologies. J Womens Health (Larchmt). 2016;25(10):1066-1072.
5. Martin AS, Monsour M, Kawwass JF, Boulet SL, Kissin DM, Jamieson DJ. Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation. Matern Child Health J. 2016;20(10):2050-6.
6. Kissin DM, Boulet SL, Jamieson DJ; Assisted Reproductive Technology Surveillance and Research Team. Fertility Treatments in the United States: Improving Access and Outcomes. Obstet Gynecol. 2016;128(2):387-90.
7. Kawwass JF, Crawford S, Hipp HS, Boulet SL, Kissin DM, Jamieson DJ; National ART Surveillance System Group. Embryo donation: national trends and outcomes, 2000 through 2013. Am J Obstet Gynecol. 2016;106(5):1107-1114.
8. Dhalwani NN, Boulet SL, Kissin DM, Zhang Y, McKane P, Bailey MA, Hood ME, Tata LJ. Assisted reproductive technology and perinatal outcomes: conventional versus discordant-sibling design. Fertil Steril. 2016;106(3):710-716.
9. Mancuso AC, Boulet SL, Duran E, Munch E, Kissin DM, Van Voorhis BJ. Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics. Fertil Steril. 2016;106(5):1107-1114.
10. Perkins KM, Boulet SL, Jamieson DJ, Kissin DM; National Assisted Reproductive Technology Surveillance System (NASS) Group. Trends and outcomes of gestational surrogacy in the United States. Fertil Steril. 2016;106(2):435-442.
11. Boulet SL, Kirby RS, Reefhuis J, Zhang Y, Sunderam S, Cohen B, Bernson D, Copeland G, Bailey MA, Jamieson DJ, Kissin DM. Assisted Reproductive Technology and Birth Defects Among Liveborn Infants in Florida, Massachusetts, and Michigan, 2000-2010. JAMA Pediatr. 2016;170(6):e154934.
12. Martin AS, Monsour M, Kissin DM, Jamieson DJ, Callaghan WM, Boulet SL. Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008-2012. Obstet Gynecol. 2016;127(1):59-66.
13. Martin AS, Zhang Y, Crawford S, Boulet SL, McKane P, Kissin DM, Jamieson DJ; States Monitoring Assisted Reproductive Technology (SMART) Collaborative. Antenatal Hospitalizations Among Pregnancies Conceived With and Without Assisted Reproductive Technology. Obstet Gynecol. 2016;127(5):941-50.
14. Luke S, Sappenfield WM, Kirby RS, McKane P, Bernson D, Zhang Y, Chuong F, Cohen B, Boulet SL, Kissin DM. The Impact of ART on Live Birth Outcomes: Differing Experiences across Three States. Paediatr Perinat Epidemiol. 2016 [in press]
15. Hipp H, Crawford S, Kawwass JF, Chang J, Kissin DM, Jamieson DJ. First trimester pregnancy loss after fresh and frozen in vitro fertilization cycles. Fertil Steril. 2016 [in press]
16. Martin AS, Monsour M, Kissin DM, Jamieson DJ, Callaghan WM, Boulet SL. Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008-2012. Obstet Gynecol. 2016;127:59-66.
17. Crawford S, Boulet SL, Mneimneh AS, Perkins KM, Jamieson DJ, Zhang Y, Kissin DM. Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches, 2012. Fertil Steril. 2016;105:444-50.
18. Chang J, Boulet SL, Jeng G, Flowers L, Kissin DM. Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the Unites States Assisted Reproductive Technology Surveillance Data, 2011-2012. Fertil Steril. 2016;105:394-400.
19. Crawford S, Boulet SL, Jamieson DJ, Stone C, Mullen J, Kissin DM. Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut. Fertil Steril. 2016;105:347-55.

 Top of Page

1. Sunderam S, Kissin DM, Crawford SB, Folger SG, Jamieson DJ, Warner L, Barfield WD. Assisted Reproductive Technology Surveillance—United States, 2013. MMWR Surveill Summ. 2015;64(11):1-25.
2. Sunderam S, Kissin DM, Crawford SB, Folger SG, Jamieson DJ, Warner L, Barfield WD; Centers for Disease Control and Prevention (CDC). Assisted Reproductive Technology Surveillance — United States, 2012. MMWR Surveill Summ. 2015;64(6):1-29.
3. Crawford S, Fussman C, Bailey M, Bernson D, Jamieson DJ, Murray-Jordan M, Kissin DM. Estimates of lifetime infertility from three states: the behavioral risk factor surveillance system. J Womens Health (Larchmt). 2015;24(7):578-86.
4. Boulet SL, Crawford S, Zhang Y, Sunderam S, Cohen B, Bernson D, McKane P, Bailey MA, Jamieson DJ, Kissin DM; States Monitoring ART Collaborative. Embryo transfer practices and perinatal outcomes by insurance mandate status. Fertil Steril. 2015;104(2):403-9.
5. Schieve LA, Fountain C, Boulet SL, Yeargin-Allsopp M, Kissin DM, Jamieson DJ, Rice C, Bearman P. Does Autism Diagnosis Age or Symptom Severity Differ Among Children According to Whether Assisted Reproductive Technology was Used to Achieve Pregnancy? J Autism Dev Disord. 2015;45(9):2991-3003.
6. Kawwass JF, Crawford S, Session DR, Kissin DM, Jamieson DJ; National ART Surveillance System Group. Endometriosis and assisted reproductive technology: United States trends and outcomes 2000-2011. Fertil Steril. 2015;103(6):1537-43.
7. Kissin DM, Boulet SL, Adashi EY. Yes, Elective Single-Embryo Transfer Should Be the Standard of Care. In: Carrell DT et al., eds. Biennial Review of Infertility: Volume 4. Switzerland: Springer International Publishing, 2015. (pp. 177-87)
8. Dunietz GL, Holzman C, McKane P, Li C, Boulet SL, Todem D, Kissin DM, Copeland G, Bernson D, Sappenfield WM, Diamond MP. Assisted reproductive technology and the risk of preterm birth among primiparas. Fertil Steril. 2015;103(4):974-979.
9. Kissin DM, Kulkarni AD, Mneimneh A, Warner L, Boulet SL, Crawford S, Jamieson DJ; National ART Surveillance System (NASS) group. Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention. Fertil Steril. 2015;103(4):954-61.
10. Boulet SL, Mehta A, Kissin DM, Warner L, Kawwass JF, Jamieson DJ. Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection. JAMA. 2015;313(3):255-63.
11. Boulet SL, Mehta A, Kissin DM. Intracytoplasmic sperm injection and reproductive outcomes–reply. JAMA. 2015;313(16):1672-3.
12. Kanter JR, Boulet SL, Kawwass JF, Jamieson DJ, Kissin DM. Trends and correlates of monozygotic twinning after single embryo transfer. Obstet Gynecol. 2015;125(1):111-7.
13. Kissin DM, Zhang Y, Boulet SL, Fountain C, Bearman P, Schieve L, Yeargin-Allsopp M, Jamieson DJ. Association of assisted reproductive technology (ART) treatment and parental infertility diagnosis with autism in ART-conceived children. Hum Reprod. 2015;30(2):454-65.
14. Kissin DM, Zhang Y, Boulet SL, Fountain C, Bearman P, Schieve L, Yeargin-Allsopp M, Jamieson DJ.  Reply: CDC analysis of ICSI/autism: association is not causation. Hum Reprod. 2015;30(7):1746.
15. Perkins KM, Boulet SL, Kissin DM, Jamieson DJ; National ART Surveillance (NASS) Group. Risk of ectopic pregnancy associated with assisted reproductive technology in the United States, 2001-2011. Obstet Gynecol. 2015;125(1):70-8.
16. Fountain C, Zhang Y, Kissin DM, Schieve LA, Jamieson DJ, Rice C, Bearman P. Association between assisted reproductive technology conception and autism in California, 1997-2007. Am J Public Health. 2015;105(5):963-71.
17. Kawwass JF, Kissin DM, Kulkarni AD, Creanga AA, Session DR, Callaghan WM, Jamieson DJ; National ART Surveillance System (NASS) Group. Safety of assisted reproductive technology in the United States, 2000-2011. JAMA. 2015;313(1):88-90.

 Top of Page

1. Sunderam S, Kissin DM, Crawford S, Folger SG, Jamieson DJ, Barfield WD; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC. Assisted reproductive technology surveillance — United States, 2011. MMWR Surveill Summ 2014;63:1-28.
2. Kissin DM, Kawwass JF, Monsour M, Boulet SL, Session DR, Jamieson DJ; National ART Surveillance System (NASS) Group. Assisted hatching: trends and pregnancy outcomes, United States, 2000-2010. Fertil Steril. 2014; S0015-0282(14)00546-9.
3. Kissin DM, Jamieson DJ, Barfield WD. Monitoring health outcomes of assisted reproductive technology. N Engl J Med. 2014;371:91-3.
4. Cohen B, Bernson D, Sappenfield W, Kirby R S, Kissin D, Zhang Y, Copeland G, Zhang Z, Macaluso M and States Monitoring Assisted Reproductive Technology (SMART) Collaborative (2014), Accuracy of Assisted Reproductive Technology Information on Birth Certificates: Florida and Massachusetts, 2004–06. Paediatric and Perinatal Epidemiology. 2014;28:181–90.
5. Grigorescu V, Zhang Y, Kissin DM, Sauber-Schatz E, Sunderam M, Kirby RS, Diop H, McKane P, Jamieson DJ. Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction. Fertil Steril. 2014;101:1019-25.
6. Kissin DM, Kulkarni AD, Kushnir VA, Jamieson DJ; National ART Surveillance System Group. Number of embryos transferred after in vitro fertilization and good perinatal outcome. Obstet Gynecol 2014;123:239-47.
7. Thoma ME, Boulet S, Martin JA, Kissin D. Births resulting from assisted reproductive technology: comparing birth certificate and National ART Surveillance System Data, 2011. Natl Vital Stat Rep. 2014;63(8):1-11.

 Top of Page

1. Kulkarni AD, Jamieson DJ, Jones HW Jr, Kissin DM, Gallo MF, Macaluso M, Adashi EY. Fertility treatments and multiple births in the United States. N Engl J Med 2013;369:2218-25.
2. Sunderam S, Kissin DM, Crawford S, Anderson JE, Folger SG, Jamieson DJ, Barfield WD; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC. Assisted reproductive technology surveillance — United States, 2010. MMWR Surveill Summ 2013;62:1-24.
3. Kawwass JF, Monsour M, Crawford S, Kissin DM, Session DR, Kulkarni AD, Jamieson DJ; for the National ART Surveillance System (NASS) Group. Trends and Outcomes for Donor Oocyte Cycles in the United States, 2000-2010. JAMA 2013;310:2426-34.
4. Kissin DM, Crawford S, Boulet SL.  The status of public reporting of clinical outcomes in assisted reproductive technology. Fertil Steril 2013;100:e16-7
5. Mneimneh AS, Boulet SL, Sunderam S, Zhang Y, Jamieson DJ, Crawford S, McKane P, Copeland G, Mersol-Barg M, Grigorescu V, Cohen B, Steele J, Sappenfield W, Diop H, Kirby RS, Kissin D, for the States Monitoring ART (SMART) Collaborative. States Monitoring Assisted Reproductive Technology (SMART) Collaborative: Data Collection, Linkage, Dissemination, and Use. J Womens Health 2013;22:571-77.
6. Kawwass JF, Crawford S, Jamieson DJ, Kissin DM, Boulet SL, Session DR. Tubal Factor Infertility and Perinatal Risk after Assisted Reproductive Technology. Obstet Gynecol 2013;121:1263-71.
7. Steinberg ML, Boulet S, Kissin D, Warner L, Jamieson DJ. Elective single embryo transfer trends and predictors of a good perinatal outcome-United States, 1999-2010. Fertil Steril 2013;99:1937-43.

 Top of Page

1. Centers for Disease Control and Prevention. Assisted Reproductive Technology Surveillance — United States, 2009. MMWR 2012;61(No. SS-7):1-23
2. Joshi N, Kissin D, Anderson JE, Session D, Macaluso M, Jamieson DJ. Trends and correlates of good perinatal outcomes in assisted reproductive technology. Obstet Gynecol. 2012;120:843-51.
3. Sauber-Schatz E, Sappenfield W, Grigorescu V, Kulkarni A, Zhang Y, Salihu HM, Rubin LP, Kirby RS, Jamieson DJ, Macaluso M. Obesity, Assisted Reproductive Technology, and Early Preterm Birth — Florida, 2004–2006. Am J Epidemiol. 2012;176:886-96.
4. Marsh CA, Farr SL, Chang J, Kissin DM, Grainger DA, Posner SF, Macaluso M, Jamieson DJ. Trends and factors associated with the Day 5 embryo transfer, assisted reproductive technology surveillance, USA, 2001-2009. Hum Reprod. 2012;27:2325-31.
5. Tepper NK, Farr SL, Cohen BB, Nannini A, Zhang Z, Anderson JE, Jamieson DJ, Macaluso M. Singleton Preterm Birth: Risk Factors and Association with Assisted Reproductive Technology. Matern Child Health J. 2012;16:807-13.
6. Kissin DM, Jamieson DJ, Barfield WD.  Assisted reproductive technology program reporting. JAMA. 2011;306:2564; author reply 2564-2565.
7. Zhang Y, Cohen B, Macaluso M, Zhang Z, Durant T, Nannini A. Probabilistic Linkage of Assisted Reproductive Technology Information with Vital Records, Massachusetts, 1997 – 2000. Matern Child Health J. 2012;16:1703-8
8. Adashi EY, Wyden R. Public reporting of clinical outcomes of assisted reproductive technology programs: implications for other medical and surgical procedures. JAMA. 2011;306:1135-6.

 Top of Page

1. D’Angelo DV, Whitehead N, Helms K, Barfield W, Ahluwalia IB. Birth outcomes of intended pregnancies among women who used assisted reproductive technology, ovulation stimulation, or no treatment. Fertil Steril. 2011;96:314-320.

 Top of Page

1. Macaluso M, Wright-Schnapp TJ, Chandra A, Johnson R, Satterwhite CL, Pulver A, Berman SM, Wang RY, Farr SL, Pollack LA: A public health focus on infertility prevention, detection, and management. Fertil Steril 2010;93:16.e1-10.
2. Zhang Z, Macaluso M, Cohen B, Schieve L, Nannini A, Chen M, Wright V.  Accuracy of Assisted Reproductive Technology Information on the Massachusetts Birth Certificate, 1997-2000.  Fertil Steril 2010;94:1657-61.

 Top of Page